Imagion Biosystems Ltd. (AU:IBX) has released an update.
Imagion Biosystems Limited has announced the issuance of 242,000 convertible notes on May 29, 2024, as detailed in their latest Appendix 3G filing. These unquoted securities, which are part of a previously announced transaction, will not be available for trading on the ASX. The move represents a significant financial development for the entity, which is expected to attract interest from investors monitoring the biotech sector.
For further insights into AU:IBX stock, check out TipRanks’ Stock Analysis page.
